NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.19 +0.24 (+0.30%) GOLD FUTURES
2,312.50 +2.90 (+0.13%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,258.73 +1,092.00 (+2.37%)
AMGN Jan 2025 310.000 call
| Previous close | 14.30 |
| Open | 13.80 |
| Bid | 14.35 |
| Ask | 15.85 |
| Strike | 310.00 |
| Expiry date | 2025-01-17 |
| Day's range | 13.80 - 13.80 |
| Contract range | N/A |
| Volume | |
| Open interest | 964 |
- Yahoo Finance Video
Amgen, DraftKings, Live Nation: Trending tickers
Shares of Amgen (AMGN) are soaring at Thursday's market close after reporting first quarter results, with revenue exceeding expectations. The biotechnology giant's revenue rose by 22% during the quarter. DraftKings (DKNG) also delivered a strong earnings report, surpassing analysts' estimates on both the top and bottom lines. Buoyed by this performance, the company raised its full-year outlook. Live Nation (LYV) topped revenue estimates in its first quarter earnings, although the company reported a loss of $0.53 per share. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Angel Smith
Investor's Business DailyAmgen Is 'Very Encouraged' With Its Obesity Study; Shares Rocket 13%
Amgen stock popped late Thursday despite its profit beat as investors watch its potential rivals to Lilly and Novo drugs.
- GuruFocus.com
Amgen Inc (AMGN) Q1 2024 Earnings: Aligns with EPS Projections Amid Revenue Growth and Challenges
Insight into Amgen's Financial Performance and Future Outlook
